These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38214949)

  • 1. Determinants of bleeding before and during immune tolerance in 222 boys with severe hemophilia A and inhibitors >5 BU.
    Fischer K; Kenet G; Kurnik K; Carcao M; Oldenburg J; Stamm-Mikkelsen T; Cid Haro AR; Koskenvuo M; Blatny J; Königs C
    Blood Adv; 2024 Jan; 8(2):369-377. PubMed ID: 38214949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ITI Treatment is not First-Choice Treatment in Children with Hemophilia A and Low-Responding Inhibitors: Evidence from a PedNet Study.
    van den Berg HM; Mancuso ME; Königs C; D'Oiron R; Platokouki H; Mikkelsen TS; Motwani J; Nolan B; Santagostino E;
    Thromb Haemost; 2020 Aug; 120(8):1166-1172. PubMed ID: 32572865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose immune tolerance induction for severe hemophilia A inhibitor patients: Immunosuppressants are generally not necessary for inhibitor-titer below 200 BU/mL.
    Li Z; Sun J; Li Z; Chen Z; Liu G; Yao W; Cheng X; Li G; Zhen Y; Ai D; Zhou Y; Mao Q; Poon MC; Wu R
    Pediatr Investig; 2024 Jun; 8(2):91-100. PubMed ID: 38910855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study.
    Kreuz W; Escuriola Ettingshausen C; Vdovin V; Zozulya N; Plyushch O; Svirin P; Andreeva T; Bubanská E; Campos M; Benedik-Dolničar M; Jiménez-Yuste V; Kitanovski L; Klukowska A; Momot A; Osmulskaya N; Prieto M; Šalek SZ; Velasco F; Pavlova A; Oldenburg J; Knaub S; Jansen M; Belyanskaya L; Walter O; ;
    Haemophilia; 2016 Jan; 22(1):87-95. PubMed ID: 26202305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose immune tolerance induction therapy in children of Arab descent with severe haemophilia A, high inhibitor titres and poor prognostic factors for immune tolerance induction treatment success.
    Elalfy M; Elghamry I; Hassab H; Elalfy O; Andrawes N; El-Ekiaby M
    Haemophilia; 2022 Jan; 28(1):65-72. PubMed ID: 34797008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New protocol for immune tolerance induction in acquired hemophilia.
    Nemes L; Pitlik E
    Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose Immune Tolerance Induction in Hemophilia: A Single-Center Experience.
    Zulfikar B; Koc B; Ozdemir N
    J Pediatr Hematol Oncol; 2019 Aug; 41(6):e355-e358. PubMed ID: 31343592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful low dose immune tolerance induction in severe haemophilia A with inhibitors below 40 Bethesda Units.
    Ter Avest PC; Fischer K; Gouw SC; Van Dijk K; Mauser-Bunschoten EP
    Haemophilia; 2010 May; 16(102):71-9. PubMed ID: 20536988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune tolerance induction in patients with severe hemophilia with inhibitors: expert panel views and recommendations for clinical practice.
    Benson G; Auerswald G; Elezović I; Lambert T; Ljung R; Morfini M; Remor E; Salek SZ
    Eur J Haematol; 2012 May; 88(5):371-9. PubMed ID: 22260405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleeding phenotype according to factor level in 825 children with nonsevere hemophilia: data from the PedNet cohort.
    de Kovel MS; Escuriola-Ettingshausen C; Königs C; Ranta S; Fischer K;
    J Thromb Haemost; 2024 Sep; 22(9):2460-2469. PubMed ID: 38866249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose immune tolerance induction alone or with immunosuppressants according to prognostic risk factors in Chinese children with hemophilia A inhibitors.
    Li Z; Chen Z; Liu G; Cheng X; Yao W; Huang K; Li G; Zhen Y; Wu X; Cai S; Poon MC; Wu R
    Res Pract Thromb Haemost; 2021 Jul; 5(5):e12562. PubMed ID: 34278191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors.
    Unuvar A; Kavakli K; Baytan B; Kazanci E; Sayli T; Oren H; Celkan T; Gursel T
    Haemophilia; 2008 Mar; 14(2):315-22. PubMed ID: 18081830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prompt immune tolerance induction at inhibitor diagnosis regardless of titre may increase overall success in haemophilia A complicated by inhibitors: experience of two U.S. centres.
    Nakar C; Manco-Johnson MJ; Lail A; Donfield S; Maahs J; Chong Y; Blades T; Shapiro A
    Haemophilia; 2015 May; 21(3):365-373. PubMed ID: 25581638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
    Kubisz P; Plamenová I; Hollý P; Stasko J
    Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors.
    Coppola A; Margaglione M; Santagostino E; Rocino A; Grandone E; Mannucci PM; Di Minno G;
    J Thromb Haemost; 2009 Nov; 7(11):1809-15. PubMed ID: 19740093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitor antibodies to factor VIII and factor IX: management.
    Lusher JM
    Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune tolerance induction therapy for patients with hemophilia A and FVIII inhibitors particularly using low-dose regimens.
    Lin PC; Liao YM; Tsai SP; Chang TT
    Pediatr Blood Cancer; 2011 Dec; 57(6):1029-33. PubMed ID: 21793191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful immune tolerance induction with low-dose coagulation factor VIII in a patient with hemophilia A from a developing country.
    Ay Y; Ersin T; Yesim O; Hilkay KT; Dilek I; Gulcihan O; Ahmet K
    Blood Coagul Fibrinolysis; 2016 Sep; 27(6):729-31. PubMed ID: 26484639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose immune tolerance induction for children with hemophilia A with poor-risk high-titer inhibitors: A pilot study in China.
    Li Z; Chen Z; Cheng X; Wu X; Li G; Zhen Y; Cai S; Poon MC; Wu R
    Res Pract Thromb Haemost; 2019 Oct; 3(4):741-748. PubMed ID: 31624794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large deletions and small insertions and deletions in the factor VIII gene predict unfavorable immune tolerance induction outcome in people with severe hemophilia A and high-responding inhibitors.
    Zuccherato LW; Souza RP; Camelo RM; Dias MM; Jardim LL; Santana MAP; Oliveira AG; Lorenzato CS; Cerqueira MH; Franco VKB; Ribeiro RA; Etto LY; Roberti MDRF; Callado FMA; de Cerqueira MAF; Pinto ISS; Garcia AA; Anegawa TH; Neves DCF; Tan DM; Tou RP; Chaves DG; van der Bom J; Rezende SM;
    Thromb Res; 2024 Oct; 242():109115. PubMed ID: 39186847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.